General Information of the Compound
Compound ID
CP0044364
Compound Name
2-(Diethylamino)-2',6'-acetoxylidide
    Show/Hide
Synonyms
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
Alfa-Dietilamino-2,6-dimetilacetanilide
Alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
Alpha-(Diethylamino)-2,6-acetoxylidide
Alpha-Diethylamino-2,6-dimethylacetanilide
Alpha-Diethylaminoaceto-2,6-xylidide
Alphacaine
Anestacon
Anestacon Jelly
CDS1_000283
Cappicaine
Cito optadren
Cuivasil
Dalcaine
Dentipatch
Dentipatch (TN)
DermaFlex
Diethylaminoaceto-2,6-xylidide
Dilocaine
Duncaine
ELA-Max
EMBOLEX
Emla Cream
Esracaine
Gravocain
Isicaina
Isicaine
Jetocaine
L-Caine
L1026_SIGMA
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
LIDOPEN
LQZ
Lanabiotic
Leostesin
Lida-Mantle
Lidocaina
Lidocaina [INN-Spanish]
Lidocaine
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine Carbonate
Lidocaine Hydrocarbonate
Lidocaine Monohydrochloride
Lidocaine [USAN:INN:JAN]
Lidocainum
Lidocainum [INN-Latin]
Lidocaton
Lidoderm
Lidoject-1
Lidoject-2
Lignocaine
Lignocainum
Lingocaine
Maricaine
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
Norwood Sunburn Spray
Octocaine
Octocaine-100
Octocaine-50
Omega-Diethylamino-2,6-dimethylacetanilide
Remicaine
Rocephin Kit
Rucaina
Solarcaine aloe extraburn relief cream
Solcain
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocard
Xylocitin
Xyloneural (free base)
Xylotox
Zilactin-L
Zingo
    Show/Hide
Structure
Formula
C14H22N2O
Molecular Weight
234.343
Canonical SMILES
CCN(CC)CC(=O)Nc1c(C)cccc1C
    Show/Hide
InChI
InChI=1S/C14H22N2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4/h7-9H,5-6,10H2,1-4H3,(H,15,17)
    Show/Hide
InChIKey
NNJVILVZKWQKPM-UHFFFAOYSA-N
CAS
137-58-6
8059-66-3
91484-71-8
8059-42-5
Physicochemical Property
logP
2.58374
Rotatable Bonds
5
Heavy Atom Count
17
Polar Areas
32.34
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
2
Complexity
17

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 3676
SID: 15196283
ChEMBL ID
CHEMBL79
DrugBank ID
DB00281
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02997, Isocitrate dehydrogenase [NADP] cytoplasmic
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000156 HT-1080 Homo sapiens (Human)  1
1
Potency ~ 461.1 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Lidocaine )
Drug Name Lidocaine
Company Endo Pharmaceuticals
Indication
Anaesthesia
Approved
Dysmenorrhea
Phase 2
Target(s)
Voltage-gated sodium channel alpha Nav1.9 (SCN11A)
Blocker